Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( (HK:6821) ) just unveiled an update.
Asymchem Laboratories (Tianjin) Co., Ltd. reported the poll results of its first extraordinary general meeting of 2026, along with separate class meetings for A shareholders and H shareholders, all held on 17 April 2026 in Tianjin. The meetings were conducted on-site and, for A shareholders, also via online voting systems, with directors largely in attendance apart from a few absent due to work commitments.
At the extraordinary general meeting, shareholders representing just over half of the company’s voting share capital participated, after excluding shares tied to repurchase, employee share plans and restricted share schemes that were required to abstain. Similar participation and abstention rules applied in the A shares and H shares class meetings, where no shareholders were mandated to vote in favour or abstain under Hong Kong listing rules, and no stated opposition to the proposed resolutions was recorded.
Turnout at the A shares class meeting reached more than half of eligible A shares, reflecting solid domestic investor engagement in corporate governance. In the H shares class meeting, a single authorized proxy represented a significant portion of the free-float H shares, underscoring the concentrated representation of overseas investors in key corporate decisions.
The most recent analyst rating on (HK:6821) stock is a Hold with a HK$120.00 price target. To see the full list of analyst forecasts on Asymchem Laboratories (Tianjin) Co., Ltd. Class H stock, see the HK:6821 Stock Forecast page.
More about Asymchem Laboratories (Tianjin) Co., Ltd. Class H
Asymchem Laboratories (Tianjin) Co., Ltd. is a PRC-incorporated pharmaceutical group listed in Hong Kong, with both A shares and H shares outstanding. The company operates in the life sciences and pharmaceutical services sector, and its shareholder base spans domestic Chinese investors and international holders via H shares.
Average Trading Volume: 420,336
Technical Sentiment Signal: Buy
Current Market Cap: HK$47.65B
Find detailed analytics on 6821 stock on TipRanks’ Stock Analysis page.